Swiss drug maker Novartis has agreed a deal with Google to develop “smart” contact lenses to help diabetics to track their blood glucose levels and for people living with presbyopia to restore the eye’s ability to focus.
The smart lens technology involves non-invasive sensors, microchips and other miniaturized electronics which are embedded within contact lenses.
“We are looking forward to working with Google to bring together their advanced technology and our extensive knowledge of biology to meet unmet medical needs,” said Novartis CEO Joseph Jimenez. “This is a key step for us to go beyond the confines of traditional disease management, starting with the eye.”
“Our dream is to use the latest technology in the miniaturization of electronics to help improve the quality of life for millions of people,” said Sergey Brin, Co-Founder, Google. “We are very excited to work with Novartis to make this dream come true.”
Financial details were not disclosed.
